Skip to main content
 

Myeloid Malignancy Interest Group

The Myeloid Malignancy Interest Group is a trans-NIH multidisciplinary network of researchers and clinicians dedicated to improving early detection, diagnosis, prognosis and development of novel therapeutics for myeloid malignancies. For more information, see https://ccr.cancer.gov/myeloid-malignancies-program

Representatives of this interest group include:
Peter D. Aplan, M.D.
Christopher S. Hourigan, M.D., D.Phil.
Paul Liu, Ph.D.
Steven Z. Pavletic, M.D.
Nirali N. Shah, M.D.

Mailing List

To join the Myeloid Malignancy Interest Group mailing list, please visit the Myeloid Malignancy Interest Group Listserv home page, then click the “Subscribe or Unsubscribe” link in the right sidebar.

Chairs

Advisors


The page was last updated on Tuesday, January 25, 2022 - 1:25pm